We started by selecting several cancer cell lines known to express VEGF-A (Supplementary Table 1) and characterized the corresponding xenografts according to several hallmarks of cancer, including cell proliferation, cell death, metastatic and angiogenic potentials. The gene discussed is VEGFA; the disease is cancer.